Finalists Named for the 2022 Hearst Health Prize in Partnership with the UCLA Center for SMART Health

Constant Therapy Named One of Three Finalists for the 2022 Hearst Health Prize

by | Oct 28, 2022

The UCLA Center for SMART Health, an interdisciplinary collaborative that looks to the integrated transformation of healthcare through emergent data and technologies, and Hearst Health, a division of Hearst and leader in care guidance, announced on PR Newswire the three finalists for the 2022 Hearst Health Prize, a $100,000 award given in recognition of excellence in data science for managing or improving health in the U.S. The 2022 Hearst Health Prize finalists, in alphabetical order, are Constant Therapy, Geisinger, and Prenosis.

Read the full press release here.

Visit Us
Follow Me